The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

Table 1

Characteristics of subjects at baseline.

Characteristic	Treatment group
	Diclofenac	Wobenzym	Placebo
Gender; (% female)	76.1	67.3	76.9
Age (years)	63.5 (47–80)^1	61 (47–80)	61.5 (44–81)
Body weight (kg)	79.5 (60–107)	79.5 (55–127)	78.0 (48–132)
Height (cm)	166 (150–183)	165 (147–193)	165 (150–185)
Body mass index	28.4 (21.5–44.3)	28.2 (21.7–37.9)	27.5 (16.2–44.4)
Months since initial diagnosis of knee osteoarthritis
	55 (<1–261)	43.5 (1–397)	47.5 (2–417)
Duration of currently active symptoms (months)
	3 (<1–245)	6 (<1–255)	5.5 (1–159)

All values presented as medians (range).